BRONCHIOLITIS OBLITERANS SYNDROME
Clinical trials for BRONCHIOLITIS OBLITERANS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS SYNDROME trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled therapy aims to save lungs after transplant
Disease control TerminatedThis study tested an inhaled form of cyclosporine A (L-CsA) plus standard care in 164 people who had a lung transplant and developed bronchiolitis obliterans, a condition that scars the small airways. The goal was to see if the drug could slow the decline in lung function over 24…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 26, 2026 11:44 UTC
-
Lung transplant drug trial halted early – what happened?
Disease control TerminatedThis early-stage trial tested the drug itacitinib in 23 people who developed bronchiolitis obliterans syndrome (a type of lung scarring) after a double lung transplant. The goal was to see if the drug was safe and could improve lung function. The study was terminated early, so re…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 22, 2026 13:54 UTC